A. Graham Pockley, PhD

A. Graham Pockley, PhD has a wealth of experience in the field of immunobiology. A. Graham began their career in 1985 as a Postgraduate Research Assistant in Reproductive Immunology (PhD) at Sheffield City Polytechnic. A. Graham then moved to Wayne State University School of Medicine in 1988 as a Postdoctoral Research Associate in Mucosal Immunology. In 1991, they became a Non-Clinical Lecturer in Transplantation Immunology at MEDICAL COLLEGE OF ST BARTHOLOMEW'S HOSPITAL & C. From 1994 to 2012, they held various roles at the University of Sheffield, including Lecturer in Immunobiology, Reader in Immunobiology, Professor of Immunobiology, and Honorary Professor. In 2012, they joined Nottingham Trent University as Director & Professor of Immunobiology of the John van Geest Cancer Research Centre, and subsequently held the roles of Associate Director & Professor of Immunobiology and Emeritus Professor of Immunobiology. In 2015, they became Chief Executive Officer of multimmune GmbH, a private, clinical-stage biopharmaceutical company. In 2021, they founded AGP Bio Limited, where they currently serve as Founder & CEO, and also joined Alphageneron Pharmaceuticals as Chief Scientific Officer (Interim) / Member of Scientific Advisory Board. A. Graham is also a Founder & CEO of Chromocyte Limited, a position they have held since 2009.

A. Graham Pockley, PhD, began their educational journey at Hymers College from 1972 to 1979. A. Graham then attended The University of Sheffield from 1979 to 1983, graduating with a BSc in Biochemistry. A. Graham continued their studies at Sheffield Hallam University from 1985 to 1988, earning a PhD in Immunology.